iBioLaunch

The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and...

Biosimilars - news, reports, views and blogs

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusi...

Baxter

Baxter is one of the 30 largest pharmaceutical companies in the world with annual sales of $7.8 billion. With a foot in both the pharmaceutical industry and medical devices, Baxter Healthcare has...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

What is Enbrel?

Technical Background Tumor necrosis factor (TNF) is a substance made by your body's immune system. People with inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, psoriatic a...

NorthWise Services to deploy Merge eClinical OS solution

NorthWise Services (NWS), a provider of data management, statistics, and medical writing services to the pharmaceutical industry, has entered into a collaboration agreement with Merge Healthcare for M...

Huntington selects Merge for PACS, iConnect Enterprise Clinical solutions

Huntington Memorial Hospital, a 625-bed, not-for-profit community-focused regional medical center, has chosen Merge Healthcare's Merge PACS and the entire iConnect Enterprise Clinical solution.

UnitedHealth Group agreed to merge with Amil for $4.9 billion

UnitedHealth Group and Amil Participações announced that the companies have agreed to merge, bringing together two leading organizations with the broad scale, distinctive resources and advanced tech...

Merge unveils new image management orthopedic solution

Merge Healthcare has unveiled a new image management and digital templating solution for orthopedics, Merge OrthoPACS.

Summit Radiology to deploy Merge radiology solutions

Summit Radiology Associates has chosen Merge Healthcare's end-to-end suite of radiology solutions to improve workflow and achieve meaningful use criteria.

Spinnovation launches biologics analysis division

Spinnovation Biologics to provide profiling and characterisation of biologics

Collaboration to Provide Clinical Trial Services in the United Kingdom for Study Data Capture, ...

Merge Healthcare, a provider of clinical systems, announced that NorthWise Services has collaborated with Merge and selected eClinical...

Biologics Contracting Demand Drives Cytovance Expansion

Cytovance Biologics is once again expanding its manufacturing capabilities as CMOs compete to keep up with pharma’s growth rate in biologics.

No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan.

OBJECTIVE: To investigate the influence of biologics on mortality and risk factors for death in rheumatoid arthritis (RA) patients. METHODS: RA patients treated with at least one dose of biologics in...

Three-Dimensional Metabolic and Radiologic Gathered Evaluation Using VR-RENDER Fusion: A Novel Tool to Enhance Accuracy in the Localization of Parathyroid Adenomas.

BACKGROUND: The aim of this study was to assess the accuracy of a novel imaging modality, three-dimensional (3D) metabolic and radiologic gathered evaluation (MeRGE), for localizing parathyroid adenom...

Clinical pharmacology considerations in biologics development.

Biologics, including monoclonal antibodies (mAbs) and other therapeutic proteins such as cytokines and growth hormones, have unique characteristics compared to small molecules. This paper starts from...

Challenges and approaches for the development of safer immunomodulatory biologics.

Immunomodulatory biologics, which render their therapeutic effects by modulating or harnessing immune responses, have proven their therapeutic utility in several complex conditions including cancer an...

Strategies for non-invasive delivery of biologics.

Macromolecular therapeutics, in particular, many biologics, is the most advancing category of drugs over conventional chemical drugs. The potency and specificity of the biologics for curing certain di...